Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA: Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 2002,8(8):878–884.PubMed 8. Darrah PA, Monaco MC, Jain S, Hondalus MK, Golenbock DT, Mosser DM: Innate immune responses to Rhodococcus equi. J Immunol 2004,173(3):1914–1924.PubMed 9. Young DB, Garbe T: Lipoprotein antigens of M. tuberculosis. Res Microbiol 1991, 142:55–65.CrossRefPubMed 10. Peirs P, Lefevre P, Boarbi S, Wang XM, Denis O, Braibant M, Pethe K, Locht C, Huygen K, Content J: Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient

in phosphate uptake selleck products and demonstrates reduced in vivo virulence. Infect Immun 2005,73(3):1898–1902.CrossRefPubMed 11. Sander P, Rezwan M, Walker B, Rampini SK, Kroppenstedt RM, Ehlers S, Keller C, Keeble JR, Hagemeier M, Colston MJ, et al.: Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol 2004,52(6):1543–1552.CrossRefPubMed 12. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT,

Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, et al.: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999,285(5428):732–736.CrossRefPubMed 13. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV: Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing selleck kinase inhibitor by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001,167(2):910–918.PubMed 14. Lopez M, Sly LM, Luu Y, Young D, Cooper H, Reiner NE: The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol 2003,170(5):2409–2416.PubMed Org 27569 15. Fortune SM, Solache A, Jaeger A, Hill PJ, Belisle JT, Bloom BR, Rubin EJ, Ernst JD: Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent

mechanisms. J Immunol 2004,172(10):6272–6280.PubMed 16. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Selleck LY2606368 Bolcskei PL, Wagner M, et al.: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001,291(5508):1544–1547.CrossRefPubMed 17. Ciaramella A, Cavone A, Santucci MB, Garg SK, Sanarico N, Bocchino M, Galati D, Martino A, Auricchio G, D’Orazio M, et al.: Induction of Apoptosis and Release of Interleukin-1 beta by Cell Wall-Associated 19-kDa Lipoprotein during the Course of Mycobacterial Infection. J Infect Dis 2004,190(6):1167–1176.CrossRefPubMed 18. Post FA, Manca C, Neyrolles O, Ryffel B, Young DB, Kaplan G: The 19 kDa lipoprotein of Mycobacterium tuberculosis inhibits Mycobacterium smegmatis induced cytokine production by human macrophages in vitro. Infect Immun 2001, 69:1433–1439.CrossRefPubMed 19.